Treatment of Radiation-Induced Cognitive Decline in Adult Brain Tumor Patients

被引：37

作者：

Cramer, Christina K. ^{[1
]}

Cummings, Tiffany L. ^{[2
]}

Andrews, Rachel N. ^{[3
]}

Strowd, Roy ^{[4
]}

Rapp, Stephen R. ^{[5
,6
]}

Shaw, Edward G. ^{[7
]}

Chan, Michael D. ^{[1
]}

Lesser, Glenn J. ^{[8
]}

机构：

[1] Wake Forest Baptist Med Ctr, Dept Radiat Oncol, Med Ctr Blvd, Winston Salem, NC 27157 USA

[2] Wake Forest Baptist Med Ctr, Dept Neurol, Winston Salem, NC 27157 USA

[3] Wake Forest Baptist Med Ctr, Dept Radiat Oncol, Sect Radiat Biol, Med Ctr Blvd, Winston Salem, NC 27157 USA

[4] Wake Forest Baptist Med Ctr, Dept Hematol Oncol, Winston Salem, NC 27157 USA

[5] Wake Forest Sch Med, Dept Psychiat & Behav Med, Med Ctr Blvd, Winston Salem, NC USA

[6] Wake Forest Sch Med, Div Publ Hlth Sci Social Sci & Hlth Policy, Med Ctr Blvd, Winston Salem, NC USA

[7] Wake Forest Baptist Hlth, Memory Counseling Program, Sect Gerontol & Geriatr Med, Sticht Ctr Hlth Aging & Alzheimers Prevent, Med Ctr Blvd, Winston Salem, NC 27157 USA

[8] Wake Forest Baptist Comprehens Canc Ctr, Oncol, Med Neurooncol & Neurooncol Res Program, Med Ctr Blvd, Winston Salem, NC 27157 USA

来源：

CURRENT TREATMENT OPTIONS IN ONCOLOGY | 2019年 / 20卷 / 05期

关键词：

Cognition; Brain; Radiation; Neuropsychology; Memory; Attention; NF-KAPPA-B; ALZHEIMERS ASSOCIATION WORKGROUPS; OLIGODENDROCYTE PROGENITOR CELLS; WHITE-MATTER HYPERINTENSITIES; DOUBLE-BLIND; PHASE-III; HIPPOCAMPAL NEUROGENESIS; X-IRRADIATION; NEUROCOGNITIVE FUNCTION; DIAGNOSTIC GUIDELINES;

D O I：

10.1007/s11864-019-0641-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Patients with either primary or metastatic brain tumors quite often have cognitive impairment. Maintaining cognitive function is important to brain tumor patients and a decline in cognitive function is generally accompanied by a decline in functional independence and performance status. Cognitive decline can be a result of tumor progression, depression/anxiety, fatigue/sleep dysfunction, or the treatments they have received. It is our opinion that providers treating brain tumor patients should obtain pre-treatment and serial cognitive testing in their patients and offer mitigating and therapeutic interventions when appropriate. They should also support cognition-focused clinical trials. © 2019, Springer Science+Business Media, LLC, part of Springer Nature.

引用

页数：16

共 96 条

[1] Elimination of microglia improves cognitive function following cranial irradiation
Acharya, Munjal M.
Green, Kim N.
Allen, Barrett D.
Najafi, Allison R.
Syage, Amber
Minasyan, Harutyun
Le, Mi T.
Kawashita, Takumi
Giedzinski, Erich
Parihar, Vipan K.
West, Brian L.
Baulch, Janet E.
Limoli, Charles L.
[J]. SCIENTIFIC REPORTS, 2016, 6
[2] The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Albert, Marilyn S.
DeKosky, Steven T.
Dickson, Dennis
Dubois, Bruno
Feldman, Howard H.
Fox, Nick C.
Gamst, Anthony
Holtzman, David M.
Jagust, William J.
Petersen, Ronald C.
Snyder, Peter J.
Carrillo, Maria C.
Thies, Bill
Phelps, Creighton H.
[J]. ALZHEIMERS & DEMENTIA, 2011, 7 (03) : 270 - 279
[3] Andrews RN, 2017, RAD RES
[4] [Anonymous], 1994, TASK FORC DSM 4 DIAG
[5] Apoptosis and proliferation of oligodendrocyte progenitor cells in the irradiated rodent spinal cord
Atkinson, SL
Li, YQ
Wong, CS
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (02): : 535 - 544
[6] Phase II study of Ginkgo biloba in irradiated brain tumor patients: effect on cognitive function, quality of life, and mood
Attia, Albert
Rapp, Stephen R.
Case, L. Doug
D'Agostino, Ralph
Lesser, Glenn
Naughton, Michelle
McMullen, Kevin
Rosdhal, Robin
Shaw, Edward G.
[J]. JOURNAL OF NEURO-ONCOLOGY, 2012, 109 (02) : 357 - 363
[7] Fractionation enhances acute oligodendrocyte progenitor cell radiation sensitivity and leads to long term depletion
Begolly, Sage
Olschowka, John A.
Love, Tanzy
Williams, Jacqueline P.
O'Banion, M. Kerry
[J]. GLIA, 2018, 66 (04) : 846 - 861
[8] Protective action of the peroxisome proliferator-activated receptor-γ agonist pioglitazone in a mouse model of Parkinson's disease
Breidert, T
Callebert, J
Heneka, MT
Landreth, G
Launay, JM
Hirsch, EC
[J]. JOURNAL OF NEUROCHEMISTRY, 2002, 82 (03) : 615 - 624
[9] Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease
Brickman, Adam M.
Honig, Lawrence S.
Scarmeas, Nikolaos
Tatarina, Oksana
Sanders, Linda
Albert, Marilyn S.
Brandt, Jason
Blacker, Deborah
Stern, Yaakov
[J]. ARCHIVES OF NEUROLOGY, 2008, 65 (09) : 1202 - 1208
[10] Contemplating Alzheimer's Disease and the Contribution of White Matter Hyperintensities
Brickman, Adam M.
[J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2013, 13 (12)

← 1 2 3 4 5 6 7 8 9 10 →